Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
7 search results for:

Insulin icodec 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 05-10-2023 | Type 2 diabetes | News | Article

    ONWARDS 5: Weekly insulin icodec with app shows real-world promise for type 2 diabetes

    Result from ONWARDS 5 trial show weekly insulin icodec plus a dosing app offers greater reductions in glycated hemoglobin than daily basal insulin analogs for type 2 diabetes.

    Author:
    Ajay Jha
    Published in:
    Ann Intern Med 2023; doi:10.7326/M23-1288
  2. 05-05-2023 | Insulin icodec | News | Article

    ONWARDS 2: Weekly insulin icodec superior to degludec in type 2 diabetes

    The results of ONWARDS 2 show significantly improved glycemic control with weekly insulin icodec versus daily insulin degludec, without significantly increased hypoglycemia, in people with type 2 diabetes.

    Author:
    Eleanor McDermid
    Published in:
    Lancet Diabetes Endocrinol 2023; doi:10.1016/S2213-8587(23)00093-1 Lancet Diabetes Endocrinol 2023; doi:10.1016/S2213-8587(23)00125-0
  3. 06-06-2022 | ADA 2022 | News | Article

    ​​​​​​​Hypoglycemia risk from insulin overdose no worse with icodec than glargine

    The risk for hypoglycemia from an accidental basal insulin overdose is no higher with weekly insulin icodec than with daily glargine U100 in people with type 2 diabetes, report researchers.

    Author:
    Eleanor McDermid
    Published in:
    ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022
  4. 29-09-2021 | EASD 2021 | News | Article

    No difference in hypoglycemia duration with insulin icodec vs insulin glargine in type 2 diabetes

    People with type 2 diabetes receiving the once-weekly basal insulin analog insulin icodec have similar hypoglycemic episode durations to those given insulin glargine, regardless of titration algorithm, initial loading dose, or prior insulin use, study findings indicate.

    Author:
    Laura Cowen
    Published in:
    EASD Annual Meeting; Sept 27–Oct 1, 2021
  5. 24-03-2021 | Basal insulin Fc | News | Article

    Second weekly insulin shows phase 2 promise for type 2 diabetes

    A novel weekly insulin achieves similar glycemic control to insulin degludec at a higher fasting glucose target, report the investigators at the virtual ENDO 2021 meeting.

    Author:
    Eleanor McDermid
    Published in:
    ENDO 2021; 20–23 March
  6. 16-06-2020 | ADA 2020 | Conference coverage | Article

    First weekly insulin shows equivalence with glargine in type 2 diabetes

    A novel insulin that can be given as a once-weekly injection has achieved promising results in a randomized phase 2 trial involving people with type 2 diabetes.

    Author:
    Eleanor McDermid
    Published in:
    ADA Scientific Sessions; 12–16 June 2020
  7. 24-06-2020 | ADA 2020 | Conference coverage | Article

    ADA 2020 goes virtual! Editorial Board conference highlights

    Listen to our Editorial Board reflecting on their ADA scientific highlights, and its novel virtual format (34:17).

  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.